C4 Therapeutics, Inc.

CCCC

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001662579

SEC filings (opens in a new tab)

No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding C4 Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of CCCC: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	119	125	+6
Shares	35.9M	37.3M	+1.43M (+4.0%)
Value	$1.15B	$904.8M	−$250.1M (−21.7%)

New holders (29)

Institutions that held C4 Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CCCC in Q1 2022
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	503,888	$12.2M	0.05%
PFM Health Sciences, LP	284,772	$6.91M	0.27%
Mariner, LLC	125,030	$3.03M	0.01%
Cypress Point Wealth Management, LLC	118,573	$2.88M	2.92%
Two Sigma Investments, LP	114,931	$2.79M	0.01%
Two Sigma Advisers, LP	42,200	$1.02M	0.00%
AlphaCrest Capital Management LLC	42,027	$1.02M	0.06%
Simplex Trading, LLC	37,246	$903.0K	0.03%
Barclays PLC	27,643	$670.0K	0.00%
Gilder Gagnon Howe & Co LLC	26,628	$646.0K	0.01%
J. Goldman & Co LP	25,930	$629.0K	0.05%
SG3 Management, LLC	25,000	$607.0K	0.17%
Jane Street Group, LLC	20,231	$491.0K	0.00%
Maven Securities LTD	18,014	$437.0K	0.09%
Concentric Capital Strategies, LP	13,700	$332.0K	0.13%
Cutler Group LP	12,744	$309.0K	0.03%
Erste Asset Management GmbH	10,700	$257.5K	0.00%
HSBC Holdings PLC	10,275	$251.0K	0.00%
Fox Run Management, L.L.C.	8,926	$217.0K	0.12%
Amalgamated Financial Corp.	6,290	$153.0K	0.00%
Lazard Asset Management LLC	3,834	$93.0K	0.00%
BIT Capital GmbH	3,800	$92.2K	0.01%
Tortoise Investment Management, LLC	1,842	$45.0K	0.01%
Caption Management, LLC	1,800	$43.0K	0.00%
Dark Forest Capital Management LP	573	$13.0K	0.00%
US Bancorp	118	$3.00K	0.00%
Lindbrook Capital, LLC	83	$2.00K	0.00%
Quadrant Capital Group LLC	22	$1.00K	0.00%
First Horizon Advisors, Inc.	15	$0	0.00%

Sold out (23)

Institutions that held C4 Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CCCC in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Ra Capital Management, L.P.	1,377,569	$44.4M
Adage Capital Partners GP, L.L.C.	996,477	$32.1M
Laurion Capital Management LP	581,028	$18.7M
Walleye Capital LLC	81,720	$2.63M
Voloridge Investment Management, LLC	60,903	$1.96M
Bank of Montreal	54,100	$1.78M
Federated Hermes, Inc.	41,897	$1.35M
Goldstream Capital Management Ltd	36,193	$1.17M
Renaissance Technologies LLC	31,300	$1.01M
Jennison Associates LLC	27,001	$869.0K
D. E. Shaw & Co., Inc.	25,735	$829.0K
Tudor Investment Corp Et Al	21,283	$685.0K
Vontobel Holding Ltd.	20,000	$644.0K
Martingale Asset Management L P	16,109	$519.0K
EMC Capital Management	10,619	$342.0K
Dymon Asia Capital (Singapore) Pte. Ltd.	8,250	$266.0K
Handelsbanken Fonder AB	8,200	$264.0K
SG Americas Securities, LLC	7,149	$230.0K
Principal Financial Group Inc	6,570	$212.0K
Quantbot Technologies LP	1,700	$54.0K
Migdal Insurance & Financial Holdings Ltd.	605	$20.0K
Cambridge Trust Co	100	$3.00K
Ford Financial Group, LLC	50	$1.00K